BioWorld-International-2006-06-28
Bacteria Genome Shows Mobile Genes Help Develop Resistance
Italy's BioXell Goes Public On Swiss Market, Gets CHF57.8M
BioXell SpA grossed CHF57.8 million (US$46.3 million) in an initial public offering on the Swiss Stock Exchange in Zurich to fund ongoing clinical and preclinical development of its portfolio of six drug candidates. (BioWorld International)

